Selected research
Industry Research
Biologic Therapeutic Drug Industry Research Report 2026
Market perspective
The global Biologic Therapeutic Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Biologic Therapeutic Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Biologic Therapeutic Drug market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Biologic Therapeutic Drug market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Biologic Therapeutic Drug include Merck and Co. Inc., Pfizer Inc., AstraZeneca, Smith Medical, Retractable Technologies, Inc., Novartis Global, H. Lundbeck A/S, GlaxoSmithKline Plc. and Concord Biotech and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Biologic Therapeutic Drug market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biologic Therapeutic Drug.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biologic Therapeutic Drug Market by Company
Merck and Co. Inc.
Pfizer Inc.
AstraZeneca
Smith Medical
Retractable Technologies, Inc.
Novartis Global
H. Lundbeck A/S
GlaxoSmithKline Plc.
Concord Biotech
Aurobindo Pharma Ltd.
Biologic Therapeutic Drug Segment by Type
Monoclonal Antibodies
Vaccines
Therapeutic Proteins
Biologic Therapeutic Drug Segment by Application
Clinical Medicine
Laboratory
Others
Biologic Therapeutic Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic Therapeutic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biologic Therapeutic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic Therapeutic Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biologic Therapeutic Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Monoclonal Antibodies
- Vaccines
- Therapeutic Proteins
Applications
- Clinical Medicine
- Laboratory
- Others
Companies covered
- Merck and Co. Inc.
- Pfizer Inc.
- AstraZeneca
- Smith Medical
- Retractable Technologies, Inc.
- Novartis Global
- H. Lundbeck A/S
- GlaxoSmithKline Plc.
- Concord Biotech
- Aurobindo Pharma Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biologic Therapeutic Drug by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Monoclonal Antibodies
- 2.2.3 Vaccines
- 2.2.4 Therapeutic Proteins
- 2.3 Biologic Therapeutic Drug by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical Medicine
- 2.3.3 Laboratory
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Biologic Therapeutic Drug Breakdown Data by Type
- 3.1 Global Biologic Therapeutic Drug Historic Market Size by Type (2021-2026)
- 3.2 Global Biologic Therapeutic Drug Forecasted Market Size by Type (2027-2032)
4 Biologic Therapeutic Drug Breakdown Data by Application
- 4.1 Global Biologic Therapeutic Drug Historic Market Size by Application (2021-2026)
- 4.2 Global Biologic Therapeutic Drug Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biologic Therapeutic Drug Market Perspective (2021-2032)
- 5.2 Global Biologic Therapeutic Drug Growth Trends by Region
- 5.2.1 Global Biologic Therapeutic Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biologic Therapeutic Drug Historic Market Size by Region (2021-2026)
- 5.2.3 Biologic Therapeutic Drug Forecasted Market Size by Region (2027-2032)
- 5.3 Biologic Therapeutic Drug Market Dynamics
- 5.3.1 Biologic Therapeutic Drug Industry Trends
- 5.3.2 Biologic Therapeutic Drug Market Drivers
- 5.3.3 Biologic Therapeutic Drug Market Challenges
- 5.3.4 Biologic Therapeutic Drug Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biologic Therapeutic Drug Players by Revenue
- 6.1.1 Global Top Biologic Therapeutic Drug Players by Revenue (2021-2026)
- 6.1.2 Global Biologic Therapeutic Drug Revenue Market Share by Players (2021-2026)
- 6.2 Global Biologic Therapeutic Drug Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biologic Therapeutic Drug Head Office and Area Served
- 6.4 Global Biologic Therapeutic Drug Players, Product Type & Application
- 6.5 Global Biologic Therapeutic Drug Manufacturers Established Date
- 6.6 Global Biologic Therapeutic Drug Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biologic Therapeutic Drug Market Size (2021-2032)
- 7.2 North America Biologic Therapeutic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biologic Therapeutic Drug Market Size by Country (2021-2026)
- 7.4 North America Biologic Therapeutic Drug Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biologic Therapeutic Drug Market Size (2021-2032)
- 8.2 Europe Biologic Therapeutic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biologic Therapeutic Drug Market Size by Country (2021-2026)
- 8.4 Europe Biologic Therapeutic Drug Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biologic Therapeutic Drug Market Size (2021-2032)
- 9.2 Asia-Pacific Biologic Therapeutic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biologic Therapeutic Drug Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biologic Therapeutic Drug Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biologic Therapeutic Drug Market Size (2021-2032)
- 10.2 South America Biologic Therapeutic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biologic Therapeutic Drug Market Size by Country (2021-2026)
- 10.4 South America Biologic Therapeutic Drug Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biologic Therapeutic Drug Market Size (2021-2032)
- 11.2 Middle East & Africa Biologic Therapeutic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Merck and Co. Inc.
- 12.1.1 Merck and Co. Inc. Company Information
- 12.1.2 Merck and Co. Inc. Business Overview
- 12.1.3 Merck and Co. Inc. Revenue in Biologic Therapeutic Drug Business (2021-2026)
- 12.1.4 Merck and Co. Inc. Biologic Therapeutic Drug Product Portfolio
- 12.1.5 Merck and Co. Inc. Recent Developments
- 12.2 Pfizer Inc.
- 12.2.1 Pfizer Inc. Company Information
- 12.2.2 Pfizer Inc. Business Overview
- 12.2.3 Pfizer Inc. Revenue in Biologic Therapeutic Drug Business (2021-2026)
- 12.2.4 Pfizer Inc. Biologic Therapeutic Drug Product Portfolio
- 12.2.5 Pfizer Inc. Recent Developments
- 12.3 AstraZeneca
- 12.3.1 AstraZeneca Company Information
- 12.3.2 AstraZeneca Business Overview
- 12.3.3 AstraZeneca Revenue in Biologic Therapeutic Drug Business (2021-2026)
- 12.3.4 AstraZeneca Biologic Therapeutic Drug Product Portfolio
- 12.3.5 AstraZeneca Recent Developments
- 12.4 Smith Medical
- 12.4.1 Smith Medical Company Information
- 12.4.2 Smith Medical Business Overview
- 12.4.3 Smith Medical Revenue in Biologic Therapeutic Drug Business (2021-2026)
- 12.4.4 Smith Medical Biologic Therapeutic Drug Product Portfolio
- 12.4.5 Smith Medical Recent Developments
- 12.5 Retractable Technologies, Inc.
- 12.5.1 Retractable Technologies, Inc. Company Information
- 12.5.2 Retractable Technologies, Inc. Business Overview
- 12.5.3 Retractable Technologies, Inc. Revenue in Biologic Therapeutic Drug Business (2021-2026)
- 12.5.4 Retractable Technologies, Inc. Biologic Therapeutic Drug Product Portfolio
- 12.5.5 Retractable Technologies, Inc. Recent Developments
- 12.6 Novartis Global
- 12.6.1 Novartis Global Company Information
- 12.6.2 Novartis Global Business Overview
- 12.6.3 Novartis Global Revenue in Biologic Therapeutic Drug Business (2021-2026)
- 12.6.4 Novartis Global Biologic Therapeutic Drug Product Portfolio
- 12.6.5 Novartis Global Recent Developments
- 12.7 H. Lundbeck A/S
- 12.7.1 H. Lundbeck A/S Company Information
- 12.7.2 H. Lundbeck A/S Business Overview
- 12.7.3 H. Lundbeck A/S Revenue in Biologic Therapeutic Drug Business (2021-2026)
- 12.7.4 H. Lundbeck A/S Biologic Therapeutic Drug Product Portfolio
- 12.7.5 H. Lundbeck A/S Recent Developments
- 12.8 GlaxoSmithKline Plc.
- 12.8.1 GlaxoSmithKline Plc. Company Information
- 12.8.2 GlaxoSmithKline Plc. Business Overview
- 12.8.3 GlaxoSmithKline Plc. Revenue in Biologic Therapeutic Drug Business (2021-2026)
- 12.8.4 GlaxoSmithKline Plc. Biologic Therapeutic Drug Product Portfolio
- 12.8.5 GlaxoSmithKline Plc. Recent Developments
- 12.9 Concord Biotech
- 12.9.1 Concord Biotech Company Information
- 12.9.2 Concord Biotech Business Overview
- 12.9.3 Concord Biotech Revenue in Biologic Therapeutic Drug Business (2021-2026)
- 12.9.4 Concord Biotech Biologic Therapeutic Drug Product Portfolio
- 12.9.5 Concord Biotech Recent Developments
- 12.10 Aurobindo Pharma Ltd.
- 12.10.1 Aurobindo Pharma Ltd. Company Information
- 12.10.2 Aurobindo Pharma Ltd. Business Overview
- 12.10.3 Aurobindo Pharma Ltd. Revenue in Biologic Therapeutic Drug Business (2021-2026)
- 12.10.4 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Product Portfolio
- 12.10.5 Aurobindo Pharma Ltd. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst